For people concerned about cognitive decline, improving and maintaining memory is incredibly important. But can you actually optimize your brain and slow the progression…
Alzheimer’s disease affects one in 10 people over the age of 65. One of the strongest genetic risk factors for developing the disease is…
When Alois Alzheimer first described the brains of people with Alzheimer’s disease more than 100 years ago, he spotted the telltale signs of the…
Alzheimer’s research is being published everyday around the world. Engaging headlines can draw readers in, but some of the articles we read are based…
While many genes can affect your risk of developing Alzheimer’s, most have a very small effect. The most common gene linked to late-onset Alzheimer’s…
Across Alzheimer’s disease and other dementias, protein plaques and deposits in the brain — like beta-amyloid, tau, and TDP-43 — are linked to inflammation,…
Two years ago, I started waking up exhausted. It didn’t matter how long I slept. I’d find myself nodding off at my computer. Whenever…
When neurologists first studied the brains of people with Alzheimer’s, more than 100 years ago, they spotted two abnormal clumps of proteins — beta-amyloid…
As the vast majority of Alzheimer’s drugs fail in clinical trials, some researchers and companies are turning to non-invasive neurotechnology as an alternative approach…
There are different modalities of drugs, delivered in different formats, that work in different ways. One type of drug you may encounter often is…
From the crispy crunch of fresh veggies to the creamy indulgence of decadent desserts, we all have different food preferences. Our palates develop uniquely,…
The U.S. Environmental Protection Agency has announced a new standard for protecting the public from fine particulate air pollution, known as PM2.5 because the…
Dementia is a term used to describe a set of symptoms: memory loss and other cognitive issues. The most common disease that causes these…
People living with Alzheimer’s disease also live with a higher risk of seizures. And that can make things complicated for doctors: Seizures are sometimes…
In the last three years, amyloid plaque-busting drugs Aduhelm (now discontinued) and Leqembi have been approved by the FDA for treating patients in the…